Inventor

SCHIENE KLAUS

DE56 patents

⚠️ This page may combine multiple inventors who share the name “SCHIENE KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHIENE KLAUS

GRUENENTHAL GMBH

Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain

Substituted tetrahydropyrrolopyrazine compounds and the use thereof in pharmaceutical compositions

Sutstituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain

Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative

Substituted 1-propiolylpiperazine compounds, their preparation and use

Combination of selected analgesics and COX-II inhibitors

Pharmaceutical composition comprising (1R,4R)-6′- fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4,b ]indol] -4-amine and paracetamol or propacetamol

Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR

Substituted imidazo[2,1-b]thiazole compounds and uses thereof

3-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives

Substituted bicyclic imidazo-3-ylamine compounds

Method of inhibiting chronification of pain

Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators

Substituted thiazoles and their use for producing drugs

Pharmaceutical combination

Combination of selected analgesics and COX-II inhibitors

Pharmaceutical combination

Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative

Pharmaceutical composition comprising (1 r,4r) -6&#39;-fluoro-N ,N-dimethyl-4-phenyl-4&#39;,9&#39;-d ihydro-3&#39;H-spiro[cyclohexane-1,1&#39;-pyrano-[3,4,b]indol]-4-amine and an oxicam

Substituted amino compounds as 5-HT/NA uptake inhibitors

Substituted phenylureas and phenylamides as vanilloid receptor ligands

Substituted phenylureas and phenylamides as vanilloid receptor ligands

Method of inhibiting inflammatory pain

Method of inhibiting chronification of pain

Pharmaceutical formulations containing substituted 2 heteroarylaminoacetic acid compounds

Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds

Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component

Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs

3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

FRANK ROBERT

Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions

Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions

Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands

Substituted phenylureas and phenylamides as vanilloid receptor ligands

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions

Substituted phenylureas and phenylamides as vanilloid receptor ligands

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions

SCHIENE KLAUS

Method of treating pain caused by inflammation

Combination of selected analgesics and COX-II inhibitors

Pharmaceutical combination

Method of inhibiting inflammatory pain

OBERBOERSCH STEFAN

Substituted sulfonamide compounds

Substituted sulfonamide compounds

Substituted sulfonamide compounds

NOXXON PHARMA AG

CGRP binding nucleic acids

GRUENENTHAL CHEMIE

Substituted cyclopentene compounds

LEE JEEWOO

Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations

MERLA BEATRIX

Substituted nicotinamide compounds and uses thereof

Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam